Main Article Content
Transdermal drug delivery system constitutes one of the most important routes for new drug delivery system. Transdermal delivery of drugs offers several advantages over conventional delivery methods. Transdermal delivery, that traditionally uses a patch containing drug substance pressed onto the skin, is non-invasive, convenient and painless, and can avoid gastrointestinal toxicity (e.g. peptic ulcer disease) and the hepatic first pass metabolism. Transdermal delivery of drugs through the skin to the systemic circulation provides a convenient route of administration for a variety of clinical indications.
In present study, attempt is made to prepare transdermal patches containing an anti- inflammatory drug such as oleanic acid along with various polymers for controlled release action. In present study, attempt was made to prepare Transdermal patches containing an anti-inflammatory drug such as oleanic acid along with various polymers for controlled release action. The Transdermal patch of oleanic acid was prepared successfully by solvent evaporation method. Transdermal patch of oleanic acid for Transdermal drug delivery was evaluated. Calibration curve was obtained; Transdermal film was prepared, overcome limitations regarding bioavailability of drug was done. Characterization was done by morphological study (SEM Analysis).
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
2. Remington’s Pharmaceutical Science, 17th ed., Mack Publishing Co., 1995, 1644-1661.
3. Das K.G., Controlled release technology- Bioengineering aspect, Willey Inter science Publication, 1983, 61-120.
4. Khouloud AA, Wasfi MO, Najin MN. Adsorption of allopurinol and ketotifen by chitosan. AAPS PharmSciTech 2001; 2(1): article 3.
5. Krishnaiah YS, Satyanarayana V, Bhaskar P. Influence of limonene on the bioavailability of nicardipine hydrochlorothiazide from membrane modulated transdermal therapeutic systems in human volunteers, Int J Pharm 2002; 247:91-102.
6. Mukherjee B, Das S, Patra B, Layek B. Nefopam containing transdermal-matrix patches based on pressure-sensitive adhesive polymers. Pharmaceutical technology 2006 March; available from:URL:http://www.pharmtech.com
7. Sadashivaiah R, Dinesh BM, Patil UA, Deasi BG, Raghu KS. Design and in vitro evaluation of haloperidol lactate transdermal patches containing ethyl cellulose povidone as film formers. Asian J Pharma Sci 2008; 2(1):43-49.
8. Patel HJ, Patel JS, Desai BG, Patel KD. Design and evaluation of amlodipine besilate transdermal patches containing film former. Int J Pharma Res Dev 2009 Sep; 7:1-12.
9. British Pharmacopoeia 2009, Vol I & II, monographs: London, her majesty office. Medical and pharmaceutical substances HPMC -3060, KTF – 3353.
10. Sathyapriya LS, Jayaprakash S, Prabhu RS, Abirami A, Subramanian K, Nagarajan M et al., An approach to the formulation and evaluation of transdermal DDS of isoxsuprine HCl. Int J Pharm Sci Tech 2008 Dec; 1(1):22-8.
11. Saxena M, Mutalik S, Reddy MS. Formulation and evaluation of transdermal patches of metoclopramide hydrochloride. Ind drugs 2006 Sep; 43(9):740-45.
12. Sankar V, Benito JD, Sivanand V, Ravichandran V, Raghuraman S, Velrajan G et al., Design and evaluation of nifedipine transdermal patches. Ind J Pharm Sci 2003; 65(5):510
13. Gupta JRD, Tripathi P, Irchhiaya R, Garud N, Dubey P, Patel JR. Formulation and evaluation of matrix type transdermal patches of Glibenclamide. Int J Pharm Sci Drug Res 2009; 1(1): 46-50.
14. Shivhare UD, Dorlikar VP, Bhusari KP, Mathur VB, Mirani BN. Effect of polymeric compositions on pharmacotechnical properties of carvedilol transdermal film. Int J Pharm Sci Nanotech 2009 June; 1(2):457-64
15. Dandagi PM, Manavi FV, Gadag AP, Mastiholimath VS, Jagdeesh T. Formulation of transdermal drug delivery of ketotifen fumarate. Ind J Pharm Sci 2003; 65(3):239-43.
16. Kulkarni RV, Mutalik S, Hiremath D. Effect of plasticizers on the permeability and mechanical properties of eudragit films for transdermal application. Ind J Pharm Sci 2002; 64(1):28-31.